# Isomorphic Labs Raises $2.1B Series B for AI Drug Discovery

> financing · REPORTED · 2026-05-01

Isomorphic Labs, the Alphabet-backed AI drug discovery spinout, announced a $2.1 billion Series B round in May 2026, its second major external funding event following a $600 million raise in spring 2025. The capital will accelerate development of its AlphaFold-based platform for designing novel medicines.

About Isomorphic Labs: Isomorphic Labs is a London-based AI drug discovery company spun out of DeepMind that uses AlphaFold and machine-learning models to design and optimize small molecule and biologic drug candidates.

- Company: Isomorphic Labs
- Sector: biotech
- Primary source: https://www.pharmavoice.com/news/biotech-large-haul-fundraising-drug-pharma/824012/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.